Clearside Biomedical Inc buy melinda
Start price
23.08.18
/
50%
€6.10
Target price
17.12.18
€9.92
Performance (%)
-81.07%
End price
17.12.18
€1.15
Summary
This prediction ended on 17.12.18 with a price of €1.15. Massive losses of -81.07% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clearside Biomedical Inc | - | - | - | - |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% | 47.267% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% | 68.687% |
Comments by melinda for this prediction
In the thread Clearside Biomedical Inc diskutieren
SecteurRecherche biotechnologique et médicale Agenda 17/09 Présentation
Develops drug therapies to treat chronic, blinding diseases of the eye
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy.
The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy.
The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Nombre d'employés : 34 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Clearside Biomedical Inc
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€1.27
28.11.19
28.11.19
-
04.11.21
04.11.21
293.70%
05.11.21
05.11.21
